logo

Five Prime Therapeutics (FPRX)



Trade FPRX now with
  Date
  Headline
4/14/2020 9:06:44 AM Five Prime Therapeutics Names Thomas Civik As President And CEO
3/13/2020 9:28:28 AM Five Prime Therapeutics Announces Publication Of The Phase 1 Bemarituzumab Study
12/26/2019 4:19:24 PM Five Prime Therapeutics Announces Resignation Of Lewis Williams From Board Of Directors
6/24/2019 4:21:54 PM Five Prime Therapeutics Appoints Lori Lyons-Williams To Its Board Of Directors
5/10/2019 8:42:01 AM Wedbush Is Cutting Five Prime Therapeutics (FPRX) FY19 Rev. Estimate To 23.3 M From 24.0 M
5/10/2019 8:41:37 AM Wedbush Is Raising Five Prime Therapeutics (FPRX) FY19 Estimate To -3.74 From -3.75
1/17/2019 6:59:29 AM Wedbush Is Increasing Five Prime Therapeutics (FPRX) FY18 Rev. Estimate To 53.6 M From 53.3 M
1/17/2019 6:59:19 AM Wedbush Is Increasing Five Prime Therapeutics (FPRX) Q4 18 Rev. Estimate To 7.8 M From 7.5 M
1/17/2019 6:58:59 AM Wedbush Is Raising Five Prime Therapeutics (FPRX) FY19 Estimate To -3.78 From -5.14
1/17/2019 6:58:47 AM Wedbush Is Increasing Five Prime Therapeutics (FPRX) Q4 19 Estimate To -0.90 From -1.33
1/17/2019 6:58:35 AM Wedbush Is Raising Five Prime Therapeutics (FPRX) Q3 19 Estimate To -0.89 From -1.30
1/17/2019 6:58:23 AM Wedbush Is Raising Five Prime Therapeutics (FPRX) Q2 19 Estimate To -0.94 From -1.29
1/17/2019 6:58:10 AM Wedbush Is Raising Five Prime Therapeutics (FPRX) Q1 19 Estimate To -1.05 From -1.23